Skip to main content
HairCited

Ácidos graxos ômega-3 para Telogen Effluvium

B

Baseado em 11 estudos com 317 participantes no total. 8/11 estudos mostram efeitos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusão

Moderate evidence suggests that omega-3 fatty acids may help support hair recovery in telogen effluvium, though the research base is limited and they are usually studied alongside other nutrients.

  • 8 out of 11 studies show positive effects, but total sample size is small (317 participants)
  • Often studied as part of multi-nutrient supplement formulations
  • No large-scale RCTs specifically for omega-3 and telogen effluvium
  • May support recovery through anti-inflammatory and nutritional mechanisms

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Efeito: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
narrative review
Herbal Remedies for Hair Loss: A Review of Efficacy and Safety.
Dose: varies by remedy and study vs: Placebo Efeito: None None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Efeito: None None
review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Efeito: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
Cohort n=200 Open-label
Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life …
Dose: high dose elemental iron (dose unspecified) vs: Placebo Efeito: Patients with baseline ferritin ≥50 ng/ml mostly 'very satisfied'; patients with ferritin <50 ng/ml None

Key Statistics

11

Estudos

317

Participantes

Positive

B

Nota

Referenced Papers

Skin appendage disorders 2025 7 citações
Acta dermatovenerologica Croatica … 2016 6 citações
Therapeutische Umschau. Revue … 2002 4 citações
Dermatologic clinics 1993 38 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
250-500 mg EPA+DHA/day
hairloss:
1,000-2,000 mg/day

Limite superior: 3,000 mg/day EPA+DHA

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
varies by remedy and study -- Positive --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
high dose elemental iron (dose unspecified) -- Positive 200
None -- Positive --
None -- Neutral 100
psychiatric and dermatological management -- Neutral 1

Melhor horário: With meals containing fat for optimal absorption; split doses if over 1,000 mg

Safety & Side Effects

Efeitos Colaterais Relatados

  • Fishy aftertaste or burping
  • Mild gastrointestinal upset (nausea, diarrhea)
  • Possible increased bleeding time at high doses
  • Unpleasant body odor at very high doses

Interações Conhecidas

  • Anticoagulants (warfarin) and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (reduces omega-3 absorption)

Ingestão máxima tolerável: 3,000 mg/day EPA+DHA

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Ácidos graxos ômega-3 help with Telogen Effluvium?
Based on 11 studies with 317 participants, there is moderate evidence from clinical studies that Ácidos graxos ômega-3 may support Telogen Effluvium management. Our evidence grade is B (Good Evidence).
How much Ácidos graxos ômega-3 should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ácidos graxos ômega-3?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal upset (nausea, diarrhea), Possible increased bleeding time at high doses, Unpleasant body odor at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ácidos graxos ômega-3 and Telogen Effluvium?
We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 317 total participants. The overall direction of effect is positive.

Related Evidence

Ácidos graxos ômega-3 para outras condições

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.